| 1 |
31734364 | In-silico and in-vitro analysis of endocan interaction with statins. | 2020 Mar 1 |
1 |
| 2 |
31935793 | Familial Combined Hyperlipidemia (FCH) Patients with High Triglyceride Levels Present with Worse Lipoprotein Function Than FCH Patients with Isolated Hypercholesterolemia. | 2020 Jan 6 |
1 |
| 3 |
31955966 | Influence of Statins on Circulating Inflammatory Cytokines in Patients With Abnormal Glucose Homeostasis: A Meta-analysis of Data From Randomized Controlled Trials. | 2020 Feb |
5 |
| 4 |
32747455 | Cholesterol induced heart valve inflammation and injury: efficacy of cholesterol lowering treatment. | 2020 Aug |
1 |
| 5 |
33224343 | Statins and C-reactive protein: in silico evidence on direct interaction. | 2020 |
1 |
| 6 |
31228727 | Statins influence biomarkers of low grade inflammation in apparently healthy people or patients with chronic diseases: A systematic review and meta-analysis of randomized clinical trials. | 2019 Nov |
1 |
| 7 |
32292723 | Efficacy of Ezetimibe/Simvastatin (10/10 mg) versus High Dose Statin in Dyslipidemia Patients: A Meta-Analysis of Randomized Controlled Trials. | 2019 Aug |
1 |
| 8 |
28550977 | The effect of Ezetimibe and Simvastatin Combination Therapy on percutaneous coronary intervention patients. | 2017 Sep 1 |
2 |
| 9 |
27022048 | Letter by Robinson Regarding Articles, "Bringing Back Targets to 'IMPROVE' Atherosclerotic Cardiovascular Disease Outcomes: The Duel for Dual Goals; Are Two Targets Better Than One?" and "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT". | 2016 Mar 29 |
1 |
| 10 |
27022050 | Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT". | 2016 Mar 29 |
1 |
| 11 |
27197424 | Paraoxonase-1 activity and pleiotropic properties of simvastatin in obese and non-obese patients with stable coronary artery disease (CAD). | 2016 |
1 |
| 12 |
27213056 | Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease. | 2016 |
1 |
| 13 |
27511325 | Simvastatin's effects on survival and outcome in traumatic braininjury patients: a comparative study. | 2016 Jan 5 |
1 |
| 14 |
28426854 | Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage: Data From the Simvastatin in Aneurysmal Subarachnoid Hemorrhage (STASH) Trial: Erratum. | 2016 Dec 1 |
1 |
| 15 |
25685360 | High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy. | 2015 |
2 |
| 16 |
26032258 | Statin treatment decreases serum angiostatin levels in patients with ischemic heart disease. | 2015 Aug 1 |
2 |
| 17 |
26280117 | Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage: Data From the Simvastatin in Aneurysmal Subarachnoid Hemorrhage (STASH) Trial. | 2015 Nov |
1 |
| 18 |
26330412 | Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. | 2015 Sep 29 |
1 |
| 19 |
26602073 | Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study). | 2015 Dec 15 |
1 |
| 20 |
25149995 | The effect of short-term simvastatin treatment on plasma adipokine levels in patients with isolated hypercholesterolemia: A preliminary report. | 2014 Oct |
1 |
| 21 |
23013513 | Effects of simvastatin and ezetimibe on interleukin-6 and high-sensitivity C-reactive protein. | 2013 Feb |
1 |
| 22 |
23159435 | Monocyte-suppressing effects of simvastatin in patients with isolated hypertriglyceridemia. | 2013 Apr |
1 |
| 23 |
23950601 | Lymphocyte-suppressing action of simvastatin in patients with isolated hypertriglyceridemia. | 2013 |
1 |
| 24 |
20678906 | Effects of simvastatin on carotenoid status in plasma. | 2012 Jan |
1 |
| 25 |
21913974 | Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein. | 2012 Dec |
2 |
| 26 |
22950641 | The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis. | 2012 |
1 |
| 27 |
23107042 | Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose. | 2012 Dec |
1 |
| 28 |
20607595 | Effects of simvastatin on proinflammatory cytokines and matrix metalloproteinases in hypercholesterolemic individuals. | 2011 Aug |
2 |
| 29 |
21276586 | Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia. | 2011 Apr 1 |
1 |
| 30 |
21477202 | A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. | 2011 Jun |
1 |
| 31 |
21865358 | Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment. | 2011 Nov |
1 |
| 32 |
22027793 | [Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction and percutaneous coronary intervention]. | 2011 Oct |
1 |
| 33 |
20084446 | Lipid and C-reactive protein levels, cardiovascular disease risk factors and simvastatin treatment in Brazilian individuals. | 2010 Aug |
2 |
| 34 |
20142117 | Efficacy of simvastatin or ezetimibe on tissue factor, von Willebrand's factor and C-reactive protein in patients with hypercholesterolaemia. | 2010 Jan |
1 |
| 35 |
20150839 | The influence of simvastatin on selected inflammatory markers in patients with chronic obstructive pulmonary disease. | 2010 |
1 |
| 36 |
20440247 | Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients: effect of statins. | 2010 Apr |
1 |
| 37 |
20445760 | Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study. | 2010 Jun |
1 |
| 38 |
20676836 | Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia. | 2010 Jul |
1 |
| 39 |
21181364 | Effects of simvastatin on the function of dendritic cells in patients with rheumatic arthritis. | 2010 Dec |
2 |
| 40 |
19151033 | Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. | 2009 Mar |
2 |
| 41 |
19195502 | Effect of beta blockers (metoprolol or propranolol) on effect of simvastatin in lowering C-reactive protein in acute myocardial infarction. | 2009 Feb 15 |
1 |
| 42 |
19301201 | Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers. | 2009 Mar |
1 |
| 43 |
19324974 | Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. | 2009 Jun 15 |
3 |
| 44 |
19555253 | Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients. | 2009 Aug |
1 |
| 45 |
19694216 | Simvastatin increases clot permeability and susceptibility to lysis in patients with LDL cholesterol below 3.4 mmol/l. | 2009 Jun |
5 |
| 46 |
18057884 | Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products. | 2008 |
5 |
| 47 |
18264935 | Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease. | 2008 Jan-Feb |
2 |
| 48 |
18855257 | Comparison of the effect of lipophilic and hydrophilic statins on serum adiponectin levels in patients with mild hypertension and dyslipidemia: Kinki Adiponectin Interventional (KAI) Study. | 2008 Oct |
1 |
| 49 |
16860807 | Effects of simvastatin on human T cells in vivo. | 2007 Jul |
2 |
| 50 |
16999946 | Reduction of C-reactive protein by a single 80 mg of simvastatin in patients with unstable angina. | 2007 Feb |
6 |